| __timestamp | Amphastar Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 176081000 |
| Thursday, January 1, 2015 | 174172000 | 157939000 |
| Friday, January 1, 2016 | 150976000 | 164073000 |
| Sunday, January 1, 2017 | 149380000 | 169243000 |
| Monday, January 1, 2018 | 187681000 | 168489000 |
| Tuesday, January 1, 2019 | 190434000 | 172526000 |
| Wednesday, January 1, 2020 | 206506000 | 200649000 |
| Friday, January 1, 2021 | 238029000 | 237513000 |
| Saturday, January 1, 2022 | 250127000 | 353358000 |
| Sunday, January 1, 2023 | 293274000 | 586886000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, understanding cost dynamics is crucial. This analysis focuses on the cost of revenue trends for Lantheus Holdings, Inc. and Amphastar Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Lantheus Holdings saw a staggering 233% increase in its cost of revenue, peaking at $586.9 million in 2023. In contrast, Amphastar Pharmaceuticals experienced a more modest 84% rise, reaching $293.3 million in the same year.
These trends highlight the differing financial strategies and market responses of these two industry players.
Analyzing Cost of Revenue: Johnson & Johnson and Amphastar Pharmaceuticals, Inc.
Cost of Revenue Trends: Sanofi vs Amphastar Pharmaceuticals, Inc.
Cost of Revenue Trends: Incyte Corporation vs Lantheus Holdings, Inc.
Cost Insights: Breaking Down Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Lantheus Holdings, Inc.
Lantheus Holdings, Inc. vs Perrigo Company plc: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Lantheus Holdings, Inc. vs Evotec SE: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Veracyte, Inc. vs Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Xenon Pharmaceuticals Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
MorphoSys AG vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and Evotec SE